- Thermo Fisher Scientific (TMO.US) shares are up about 4% in premarket trading today following the announcement of a strategic collaboration with OpenAI.
- This is yet another example of a company outside the traditional technology sector announcing a partnership with OpenAI in an effort to be seen by investors as a beneficiary of the AI revolution.
- Thermo Fisher Scientific (TMO.US) shares are up about 4% in premarket trading today following the announcement of a strategic collaboration with OpenAI.
- This is yet another example of a company outside the traditional technology sector announcing a partnership with OpenAI in an effort to be seen by investors as a beneficiary of the AI revolution.
Thermo Fisher Scientific (TMO.US) shares are up about 4% in premarket trading today following the announcement of a strategic collaboration with OpenAI. The company is implementing artificial intelligence solutions in key areas of its business, from clinical research and customer service to the Accelerator™ Drug Development platform and internal ChatGPT Enterprise implementations, with the aim of reducing the time to market for new drugs, managing innovation more effectively, and making better use of resources.
This is another example of a company outside the traditional technology sector announcing a partnership with OpenAI in an effort to be seen by investors as a beneficiary of the AI revolution that is driving the valuations of giants such as Nvidia, Microsoft, and Alphabet. The market clearly rewards any attempts to implement AI-based solutions: there is an automatic narrative about the possibility of repeating the success of technology companies whose shares have been gaining for months thanks to the AI boom. Hence today's positive reaction to TMO's stock price – investors see an opportunity for other sectors to jump on the fast-moving AI technology bandwagon, seeking to replicate the success of companies that have been key beneficiaries of this transformation for some time.
Just before the opening of Wall Street, the company's shares are up 4% and testing the recent local highs from October.
Source: xStation
Stock of the Week - Lam Research Corp (16.10.2025)
Salesforce surges 8% amid positive long-term revenue forecast📈
DE40: Europe moves sideways, Nestle gains
Nestlé: Steady Growth and Ambitious Restructuring Drive Share Price Surge
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
